Literature DB >> 16549825

Medullary renal cell carcinoma and response to therapy with bortezomib.

Ellen A Ronnen, G Varuni Kondagunta, Robert J Motzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16549825     DOI： 10.1200/JCO.2005.05.0344

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil.

Authors:  Marina Cavalcanti Maroja Silvino; Camila Motta Venchiarutti Moniz; Gustavo Henrique Munhoz Piotto; Sheila Siqueira; Ariel Galapo Kann; Carlos Dzik
Journal:  Rare Tumors       Date:  2013-08-20

Review 2.  Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.

Authors:  Simon Chowdhury; Marc R Matrana; Christopher Tsang; Bradley Atkinson; Toni K Choueiri; Nizar M Tannir
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

3.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

4.  Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases.

Authors:  Zhenshan Shi; Qian Zhuang; Ruixiong You; Yueming Li; Jian Li; Dairong Cao
Journal:  Oncol Lett       Date:  2015-11-09       Impact factor: 2.967

5.  Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

Authors:  Maria I Carlo; Joshua Chaim; Sujata Patil; Yelena Kemel; Alison M Schram; Kaitlin Woo; Devyn Coskey; Gouri J Nanjangud; Martin H Voss; Darren R Feldman; James J Hsieh; A Ari Hakimi; Ying-Bei Chen; Robert J Motzer; Chung-Han Lee
Journal:  Clin Genitourin Cancer       Date:  2017-04-26       Impact factor: 2.872

6.  Renal medullary carcinoma: a nearly fatal malignancy specifically affecting patients with a so-called benign condition.

Authors:  Yamila Goenaga-Vázquez; Gloria Colón; Nilka Barrios; María Correa
Journal:  CEN Case Rep       Date:  2018-02-02

7.  Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.

Authors:  Pavlos Msaouel; Andrew L Hong; Elizabeth A Mullen; Michael B Atkins; Cheryl Lyn Walker; Chung-Han Lee; Marcus A Carden; Giannicola Genovese; W Marston Linehan; Priya Rao; Maria J Merino; Howard Grodman; Jeffrey S Dome; Conrad V Fernandez; James I Geller; Andrea B Apolo; Najat C Daw; H Courtney Hodges; Marva Moxey-Mims; Darmood Wei; Donald P Bottaro; Michael Staehler; Jose A Karam; W Kimryn Rathmell; Nizar M Tannir
Journal:  Clin Genitourin Cancer       Date:  2018-09-12       Impact factor: 2.872

Review 8.  Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.

Authors:  W Marston Linehan; Ramaprasad Srinivasan; Jorge A Garcia
Journal:  Semin Oncol       Date:  2013-08       Impact factor: 4.929

Review 9.  Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies.

Authors:  Alexander Sankin; A Ari Hakimi; James J Hsieh; Ana M Molina
Journal:  Front Oncol       Date:  2015-04-08       Impact factor: 6.244

10.  Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery.

Authors:  Jielin Li; Laura Pohl; Julia Schüler; Nina Korzeniewski; Philipp Reimold; Adam Kaczorowski; Weibin Hou; Stefanie Zschäbitz; Cathleen Nientiedt; Dirk Jäger; Markus Hohenfellner; Anette Duensing; Stefan Duensing
Journal:  Biomedicines       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.